DONGWHA PHARM.CO.,LTD Logo

DONGWHA PHARM.CO.,LTD

Researches, develops, and sells a diverse range of healthcare products.

000020 | KO

Overview

Corporate Details

ISIN(s):
KR7000020008
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로9길 20, 중구

Description

Dongwha Pharm is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a diverse range of healthcare products. Its portfolio includes ethical (prescription) pharmaceuticals, over-the-counter (OTC) drugs, medical devices, quasi-drugs, health functional foods, cosmetics, and beverages. The company's research and development efforts focus on various therapeutic areas, including alimentary and cardiovascular systems. Dongwha Pharm actively pursues innovation through its drug pipeline, clinical trials, and strategic investments in emerging fields like digital therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-20 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 10.5 KB
2023-02-20 00:00
현금ㆍ현물배당결정
Korean 8.2 KB
2023-02-20 00:00
주식등의대량보유상황보고서(일반)
Korean 114.8 KB
2023-02-20 00:00
주주총회소집결의
Korean 17.5 KB
2023-02-13 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 14.1 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 1.4 MB
2022-10-24 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 10.4 KB
2022-09-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2022-09-30 00:00
최대주주변경
Korean 22.9 KB
2022-09-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2022-09-30 00:00
최대주주등소유주식변동신고서(최대주주변경시)
Korean 94.1 KB
2022-09-30 00:00
주식등의대량보유상황보고서(일반)
Korean 119.4 KB
2022-08-23 00:00
주식등의대량보유상황보고서(일반)
Korean 113.0 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean 1.3 MB
2022-07-25 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 10.5 KB

Automate Your Workflow. Get a real-time feed of all DONGWHA PHARM.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGWHA PHARM.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGWHA PHARM.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.